Implications of Genetic Testing in Dilated
Implications of Genetic Testing in Dilated Cardiomyopathy
Background – Genetic analysis is a first-tier test in dilated cardiomyopathy (DCM). Electrical phenotypes are common in genetic DCM but their exact contribution to the clinical course and outcome is unknown. We determined the prevalence of pathogenic gene variants in a large unselected DCM population, and determined the role of electrical phenotypes in association with outcome.
Methods – This study included 689 DCM patients from the Maastricht Cardiomyopathy Registry, undergoing genetic evaluation using a 48 cardiomyopathy-associated gene-panel, echocardiography, endomyocardial biopsies and Holter monitoring. Upon detection of a pathogenic variant in a DCM patient, familial segregation was performed. Outcome was defined as cardiovascular death, heart transplantation, heart failure hospitalization and/or occurrence of life-threatening arrthymias.
Results – A (likely) pathogenic gene variant was found in 19% of patients, varying from 36% in familial to 13% in non-familial DCM. Family segregation analysis showed familial disease in 46% of DCM patients who were initially deemed non-familial by history. Overall, 18% of patients with a non-genetic risk factor had a pathogenic gene variant.
Almost all pathogenic gene variants occurred in just 12 genes previously shown to have robust disease association with DCM. Genetic DCM was independently associated with electrical phenotypes such as atrial fibrillation (AF), non-sustained ventricular tachycardia (NSVT) and AV-block (AVB), and inversely correlated with the presence of a left bundle branch block(p<0.01). After a median follow-up of 4 years, event-free survival was reduced in genetic versus non-genetic DCM patients(p=0.01). This effect on outcome was mediated by the associated electrical phenotypes of genetic DCM(p<0.001).
Conclusions – One in five patients with an established non-genetic risk factor or a non-familial disease still carries a pathogenic gene variant. Genetic DCM is characterized by a profile of electrical phenotypes (AF, NSVT and AVB), which carries increased risk for adverse outcomes. Based on these findings, we envisage a broader role for genetic testing in DCM.
Human Galectin-1 |
|||
| MBS691972-005mg | MyBiosource | 0.05mg | EUR 450 |
Human Galectin-1 |
|||
| MBS691972-5x005mg | MyBiosource | 5x0.05mg | EUR 1725 |
Galectin-1， Human |
|||
| E34M148H | EnoGene | 5 μg | EUR 155 |
Galectin-1 Human |
|||
| GWB-DAB7E1 | GenWay Biotech | 0.05 mg | Ask for price |
Galectin-1, Human |
|||
| MBS8575305-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-1, Human |
|||
| MBS8575305-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Mouse anti Human Galectin-1 Antibody, Mouse MAb |
|||
| MBS2543309-006mL | MyBiosource | 0.06mL | EUR 250 |
Mouse anti Human Galectin-1 Antibody, Mouse MAb |
|||
| MBS2543309-012mL | MyBiosource | 0.12mL | EUR 370 |
Mouse anti Human Galectin-1 Antibody, Mouse MAb |
|||
| MBS2543309-02mL | MyBiosource | 0.2mL | EUR 550 |
Human Galectin-1 (Gal-1) Antibody |
|||
| 30005-05111 | AssayPro | 150 ug | EUR 215 |
Human Galectin( Galectin) Elisa Kit |
|||
| EK711568 | AFG Bioscience LLC | 96 Wells | EUR 0.18 |
RABBIT ANTI HUMAN GALECTIN-3:Biotin |
|||
| MBS222930-005mg | MyBiosource | 0.05mg | EUR 655 |
RABBIT ANTI HUMAN GALECTIN-3:Biotin |
|||
| MBS222930-5x005mg | MyBiosource | 5x0.05mg | EUR 2780 |
Rabbit Anti-Human Galectin-1 |
|||
| 102-PA131 | Angio Proteomie | 100ug | EUR 240 |
Anti-Human Galectin-1 Antibody |
|||
| 102-P131 | ReliaTech | 100 µg | EUR 245.7 |
|
Description: Galectin-1, also known as L14, BHL and galaptin, is a monomeric or homodimeric prototype galectin that is expressed in a variety of cells and tissues including muscle, heart, liver, prostate, lymph nodes, spleen, thymus, placenta, testis, retina, macrophages, B cells, T cells, dendritic cells, and tumor cells. It preferentially binds laminin, fibronectin, 90K/Mac2BP, CD45, CD43, CD7, CD2, CD3, and ganglioside GM1. Galectin-1 modulates cell growth and proliferation, either positively or negatively, depending on the cell type and activation status. It controls cell survival by inducing apoptosis of activated T cells and immature thymocytes. It modulates cytokine secretion by inducing Th2 type cytokines and inhibiting proinflammatory cytokine production. Galectin1 can also modulate cel-lcell as well as cell-lmatrix interactions and depending on the cell type and developmental stage, promote cell attachment or detachment. Galectin-1 has immunosuppressive and anti-inflammatory properties and has been shown to suppress acute and chronic inflammation and autoimmunity. Human and mouse galectin1 share about 88% amino acid sequence similarity. |
|||
Anti-Human Galectin-1 Antibody |
|||
| 102-PA131AG | ReliaTech | 50 µg | EUR 157.5 |
|
Description: Galectin-1, also known as L14, BHL and galaptin, is a monomeric or homodimeric prototype galectin that is expressed in a variety of cells and tissues including muscle, heart, liver, prostate, lymph nodes, spleen, thymus, placenta, testis, retina, macrophages, B cells, T cells, dendritic cells, and tumor cells. It preferentially binds laminin, fibronectin, 90K/Mac2BP, CD45, CD43, CD7, CD2, CD3, and ganglioside GM1. Galectin-1 modulates cell growth and proliferation, either positively or negatively, depending on the cell type and activation status. It controls cell survival by inducing apoptosis of activated T cells and immature thymocytes. It modulates cytokine secretion by inducing Th2 type cytokines and inhibiting proinflammatory cytokine production. Galectin1 can also modulate cel-lcell as well as cell-lmatrix interactions and depending on the cell type and developmental stage, promote cell attachment or detachment. Galectin-1 has immunosuppressive and antiinflammatory properties and has been shown to suppress acute and chronic inflammation and autoimmunity. Human and mouse galectin1 share about 88% amino acid sequence similarity. |
|||
Anti-Human Galectin-1 Antibody |
|||
| 102-PA131S | ReliaTech | 100 µg | EUR 126 |
|
Description: Galectin-1, also known as L14, BHL and galaptin, is a monomeric or homodimeric prototype galectin that is expressed in a variety of cells and tissues including muscle, heart, liver, prostate, lymph nodes, spleen, thymus, placenta, testis, retina, macrophages, B cells, T cells, dendritic cells, and tumor cells. It preferentially binds laminin, fibronectin, 90K/Mac2BP, CD45, CD43, CD7, CD2, CD3, and ganglioside GM1. Galectin-1 modulates cell growth and proliferation, either positively or negatively, depending on the cell type and activation status. It controls cell survival by inducing apoptosis of activated T cells and immature thymocytes. It modulates cytokine secretion by inducing Th2 type cytokines and inhibiting proinflammatory cytokine production. Galectin1 can also modulate cel-lcell as well as cell-lmatrix interactions and depending on the cell type and developmental stage, promote cell attachment or detachment. Galectin-1 has immunosuppressive and antiinflammatory properties and has been shown to suppress acute and chronic inflammation and autoimmunity. Human and mouse galectin1 share about 88% amino acid sequence similarity. |
|||
human anti-human galectin-3 mAb(2D) |
|||
| E4A09H10-2D | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human galectin-3 mAb(5F) |
|||
| E4A09H10-5F | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human galectin-3 mAb(A5) |
|||
| E4A09H10-A5 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human galectin-3 mAb(G2) |
|||
| E4A09H10-G2 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human galectin-3 mAb(H3) |
|||
| E4A09H10-H3 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human galectin-3 mAb(T1) |
|||
| E4A09H10-T1 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
Human Galectin-1 (LGALS1) |
|||
| 1-CSB-EP012882HU | Cusabio |
|
|
|
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli |
|||
Human Galectin-1 (LGALS1) |
|||
| 1-CSB-EP012882HUb1 | Cusabio |
|
|
|
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli |
|||
Mouse anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543310-006mL | MyBiosource | 0.06mL | EUR 250 |
Mouse anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543310-012mL | MyBiosource | 0.12mL | EUR 370 |
Mouse anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543310-02mL | MyBiosource | 0.2mL | EUR 550 |
human anti-human galectin-3 mAb(N13) |
|||
| E4A09H10-N13 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
Human Galectin-1 Protein |
|||
| PRP1033-100g | Abbkine | 100 µg | EUR 309 |
Human Galectin-1 Protein |
|||
| PRP1033-1mg | Abbkine | 1 mg | EUR 1099 |
Human Galectin-1 Protein |
|||
| PRP1033-20g | Abbkine | 20 µg | EUR 79 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543912-006mL | MyBiosource | 0.06mL | EUR 250 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543912-012mL | MyBiosource | 0.12mL | EUR 370 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543912-02mL | MyBiosource | 0.2mL | EUR 550 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543913-006mL | MyBiosource | 0.06mL | EUR 250 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543913-012mL | MyBiosource | 0.12mL | EUR 370 |
Rabbit anti Human Galectin-1/LGALS1 Monoclonal Antibody |
|||
| MBS2543913-02mL | MyBiosource | 0.2mL | EUR 550 |
Anti Human Galectin-3 Polyclonal Antibody |
|||
| KH040 | Sceti | each | EUR 778.8 |
|
Description: The Anti Human Galectin-3 Polyclonal Antibody is available in Europe and for worldwide shipping via Gentaur. |
|||
Human Galectin-3(Galectin-3)ELISA Kit |
|||
| YLA0216HU-48T | Shanghai YL Biotech | 48T | Ask for price |
Human Galectin-3(Galectin-3)ELISA Kit |
|||
| YLA0216HU-96T | Shanghai YL Biotech | 96T | Ask for price |
Recombinant Human Galectin-1 |
|||
| 7-00427 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Galectin-1 |
|||
| 7-00428 | CHI Scientific | 50µg | Ask for price |
Recombinant Human Galectin-1 |
|||
| 7-00429 | CHI Scientific | 1mg | Ask for price |
Recombinant Human Galectin-1 |
|||
| AP60482 | SAB | 100ug | EUR 449 |
Recombinant Human Galectin-1 |
|||
| HEOPP-0710 | Cyagen | 10ug | Ask for price |
RECOMBINANT HUMAN GALECTIN-1 |
|||
| GWB-BEA2B0 | GenWay Biotech | 0.05 mg | Ask for price |
Recombinant Human Galectin-1 |
|||
| cyt-544-10g | ProSpec Tany | 10µg | EUR 60 |
Recombinant Human Galectin-1 |
|||
| cyt-544-1mg | ProSpec Tany | 1mg | EUR 1350 |
Recombinant Human Galectin-1 |
|||
| cyt-544-50g | ProSpec Tany | 50µg | EUR 145 |
Recombinant Human Galectin-1 |
|||
| MBS143303-001mg | MyBiosource | 0.01mg | EUR 240 |
Recombinant Human Galectin-1 |
|||
| MBS143303-005mg | MyBiosource | 0.05mg | EUR 310 |
Recombinant Human Galectin-1 |
|||
| MBS143303-1mg | MyBiosource | 1mg | EUR 1515 |
Recombinant Human Galectin-1 |
|||
| MBS143303-5x1mg | MyBiosource | 5x1mg | EUR 6485 |
RECOMBINANT HUMAN GALECTIN-1 |
|||
| MBS232407-005mg | MyBiosource | 0.05mg | EUR 500 |
RECOMBINANT HUMAN GALECTIN-1 |
|||
| MBS232407-5x005mg | MyBiosource | 5x0.05mg | EUR 2070 |
Recombinant Human Galectin-1 |
|||
| P1229-.01 | ApexBio | 10ug | EUR 108.8 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human Galectin-1 |
|||
| P1229-.1 | ApexBio | 10X10ug | EUR 450.4 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human Galectin-1 |
|||
| P1229-.5 | ApexBio | 50X10ug | EUR 1010.4 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant Human Galectin-1 |
|||
| MBS9420409-002mg | MyBiosource | 0.02mg | EUR 285 |
Recombinant Human Galectin-1 |
|||
| MBS9420409-01mg | MyBiosource | 0.1mg | EUR 470 |
Recombinant Human Galectin-1 |
|||
| MBS9420409-1mg | MyBiosource | 1mg | EUR 1785 |
Recombinant Human Galectin-1 |
|||
| MBS9420409-5x1mg | MyBiosource | 5x1mg | EUR 7885 |
Recombinant Human Galectin-1 |
|||
| MBS966052-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 255 |
Recombinant Human Galectin-1 |
|||
| MBS966052-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 405 |
Recombinant Human Galectin-1 |
|||
| MBS966052-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1425 |
Recombinant Human Galectin-1 |
|||
| MBS966052-5x1mgEColi | MyBiosource | 5x1mg(E-Coli) | EUR 6215 |
anti- Galectin-1 antibody |
|||
| FNab03314 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against Galectin-1 |
|||
anti- Galectin-1 antibody |
|||
| FNab03315 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against Galectin-1 |
|||
Anti- Galectin-1 Antibody |
|||
| GWB-6F6392 | GenWay Biotech | 0.1 mg | Ask for price |
Human Galectin 1 Protein |
|||
| 20-abx066725 | Abbexa |
|
|
Human Galectin-1 Antibody Pair Set |
|||
| ABPR-ZB244 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
|
Description: Quantitative determination of Human Galectin-1 |
|||
Galectin-1, human recombinant |
|||
| 4648-10 | Biovision | each | EUR 170.4 |
Galectin-1, human recombinant |
|||
| 4648-1000 | Biovision | each | EUR 1977.6 |
Galectin-1, human recombinant |
|||
| 4648-50 | Biovision | each | EUR 314.4 |
Galectin-1 Human Recombinant |
|||
| rAP-2252 | Angio Proteomie | Inquiry | Ask for price |
Galectin-1 (human), (recombinant) |
|||
| MBS567229-01mg | MyBiosource | 0.1mg | EUR 750 |
Galectin-1 (human), (recombinant) |
|||
| MBS567229-5x01mg | MyBiosource | 5x0.1mg | EUR 3320 |
Anti-Human Galectin-1 Azide Free |
|||
| MBS335796-02mg | MyBiosource | 0.2mg | EUR 290 |
Anti-Human Galectin-1 Azide Free |
|||
| MBS335796-05mg | MyBiosource | 0.5mg | EUR 555 |
Anti-Human Galectin-1 Azide Free |
|||
| MBS335796-5x05mg | MyBiosource | 5x0.5mg | EUR 2465 |
Anti-Human Galectin-1 Azide Free |
|||
| MBS335797-02mg | MyBiosource | 0.2mg | EUR 290 |
Anti-Human Galectin-1 Azide Free |
|||
| MBS335797-05mg | MyBiosource | 0.5mg | EUR 555 |
Anti-Human Galectin-1 Azide Free |
|||
| MBS335797-5x05mg | MyBiosource | 5x0.5mg | EUR 2465 |
Human Galectin-1 ELISA Kit |
|||
| EK5323 | SAB | 96 tests | EUR 599 |
Human Galectin-1 ELISA Kit |
|||
| IHULGALS1KT | Innovative research | each | EUR 702 |
|
Description: Human Galectin-1 ELISA Kit |
|||
Human Galectin-1 ELISA Kit |
|||
| MBS765403-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3900 |
Human Galectin-1 ELISA Kit |
|||
| MBS765403-48StripWells | MyBiosource | 48-Strip-Wells | EUR 340 |
Human Galectin-1 ELISA Kit |
|||
| MBS765403-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2045 |
Human Galectin-1 ELISA Kit |
|||
| MBS765403-96StripWells | MyBiosource | 96-Strip-Wells | EUR 455 |
Human Galectin-1 ELISA Kit |
|||
| MBS8414441-1Kit | MyBiosource | 1Kit | EUR 755 |
Human Galectin-1 ELISA Kit |
|||
| MBS8414441-5x1Kit | MyBiosource | 5x1Kit | EUR 3455 |
Human Galectin-1 ELISA Kit |
|||
| MBS2883188-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3290 |
Human Galectin-1 ELISA Kit |
|||
| MBS2883188-48StripWells | MyBiosource | 48-Strip-Wells | EUR 340 |
Human Galectin-1 ELISA Kit |
|||
| MBS2883188-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1800 |
Human Galectin-1 ELISA Kit |
|||
| MBS2883188-96StripWells | MyBiosource | 96-Strip-Wells | EUR 435 |
Recombinant Human Galectin 1 |
|||
| MBS7609301-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Human Galectin 1 |
|||
| MBS7609301-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Human Galectin 1 |
|||
| MBS7609301-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Human Galectin 1 |
|||
| MBS7609301-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
Human Galectin-1 (LEG1) Protein |
|||
| abx690252-100g | Abbexa | 100 µg | EUR 837.5 |
Human Galectin-1 (LEG1) Protein |
|||
| abx690252-20g | Abbexa | 20 µg | EUR 350 |
Human Galectin 1 CLIA Kit |
|||
| MBS8425460-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Human Galectin 1 (GAL1) ELISA |
|||
| KT-15605 | Kamiya Biomedical Company | 96 tests | EUR 952 |
Human Galectin-1 (LGALS1) Protein |
|||
| abx670211-50ug | Abbexa | 50 ug | EUR 661.2 |
Galectin-1, 1-135aa, Human, E Coli |
|||
| MBS203386-002mg | MyBiosource | 0.02mg | EUR 190 |
Galectin-1, 1-135aa, Human, E Coli |
|||
| MBS203386-01mg | MyBiosource | 0.1mg | EUR 280 |
Galectin-1, 1-135aa, Human, E Coli |
|||
| MBS203386-05mg | MyBiosource | 0.5mg | EUR 570 |
Galectin-1, 1-135aa, Human, E Coli |
|||
| MBS203386-5x05mg | MyBiosource | 5x0.5mg | EUR 2325 |
Mouse Monoclonal anti-human Galectin-1 |
|||
| hAP-1228 | Angio Proteomie | 50ug | EUR 400 |
Sheep Polyclonal anti-Human Galectin-1 |
|||
| hAP-5905 | Angio Proteomie | 50ug | EUR 400 |
Human Galectin 1 ELISA kit |
|||
| E01A4669 | BlueGene | 96T | EUR 700 |
|
Description: ELISA |
|||
Human Galectin 1 ELISA kit |
|||
| E01G0038-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Human Galectin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Galectin 1 ELISA kit |
|||
| E01G0038-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Human Galectin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Galectin 1 ELISA kit |
|||
| E01G0038-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Human Galectin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Galectin 1 ELISA Kit |
|||
| MBS029650-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Human Galectin 1 ELISA Kit |
|||
| MBS029650-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Human Galectin 1 ELISA Kit |
|||
| MBS029650-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Human Galectin 1 ELISA Kit |
|||
| MBS029650-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
Human Galectin 1 ELISA Kit |
|||
| IHUGAL1KT | Innovative research | each | EUR 667 |
|
Description: Human Galectin 1 ELISA Kit |
|||
Human Galectin 1 ELISA Kit |
|||
| MBS721030-48StripWellsCompetitive | MyBiosource | 48-Strip-Wells-(Competitive) | EUR 485 |
Human Galectin 1 ELISA Kit |
|||
| MBS721030-48StripWellsSandwich | MyBiosource | 48-Strip-Wells-(Sandwich) | EUR 485 |
Human Galectin 1 ELISA Kit |
|||
| MBS721030-5x96StripWellsCompetitive | MyBiosource | 5x96-Strip-Wells-(Competitive) | EUR 3020 |
Human Galectin 1 ELISA Kit |
|||
| MBS721030-96StripWellsCompetitive | MyBiosource | 96-Strip-Wells-(Competitive) | EUR 690 |
Human Galectin 1 ELISA Kit |
|||
| MBS721030-96StripWellsSandwich | MyBiosource | 96-Strip-Wells-(Sandwich) | EUR 690 |
Human Galectin 1 ELISA Kit |
|||
| MBS8248373-5x96Tests | MyBiosource | 5x96Tests | EUR 2880 |
Human Galectin 1 ELISA Kit |
|||
| MBS8248373-96Tests | MyBiosource | 96Tests | EUR 645 |
Human Galectin-1 (GAL-1) ELISA Kit |
|||
| MBS3800380-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Human Galectin-1 (GAL-1) ELISA Kit |
|||
| MBS3800380-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Human Galectin-1 (GAL-1) ELISA Kit |
|||
| MBS3800380-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Human Galectin-1 (GAL-1) ELISA Kit |
|||
| MBS3800380-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
Human Galectin-3 |
|||
| MBS691554-001mg | MyBiosource | 0.01mg | EUR 300 |
Human Galectin-3 |
|||
| MBS691554-005mg | MyBiosource | 0.05mg | EUR 450 |
Human Galectin-3 |
|||
| MBS691554-5x005mg | MyBiosource | 5x0.05mg | EUR 1725 |
Galectin-10， Human |
|||
| E34M155H | EnoGene | 5 μg | EUR 155 |
Galectin-12， Human |
|||
| E34M156H | EnoGene | 5 μg | EUR 155 |
Galectin-13， Human |
|||
| E34M157H | EnoGene | 5 μg | EUR 155 |
Galectin-14， Human |
|||
| E34M158H | EnoGene | 5 μg | EUR 155 |
Galectin-16， Human |
|||
| E34M159H | EnoGene | 5 μg | EUR 155 |
Galectin-10, Human |
|||
| MBS8575312-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-10, Human |
|||
| MBS8575312-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Galectin-12, Human |
|||
| MBS8575313-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-12, Human |
|||
| MBS8575313-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Galectin-13, Human |
|||
| MBS8575314-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-13, Human |
|||
| MBS8575314-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Galectin-14, Human |
|||
| MBS8575315-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-14, Human |
|||
| MBS8575315-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Galectin-16, Human |
|||
| MBS8575316-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-16, Human |
|||
| MBS8575316-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Human, Rat, Mouse Galectin 1 antibody |
|||
| P0500 | Omnimabs | 100ul | EUR 150 |
Recombinant Human Galectin-1(LGALS1) |
|||
| AP70493 | SAB | 1mg | EUR 1978 |
Recombinant Human Galectin-1 (LGALS1) |
|||
| CSB-EP012882HU | Cusabio | 1598 mg | Ask for price |
Recombinant Human Galectin-1 (LGALS1) |
|||
| CSB-EP012882HUb1 | Cusabio | 1599 mg | Ask for price |
Recombinant Human Galectin-1 (LGALS1) |
|||
| Z101845 | ABM | 15 µg | EUR 105 |
|
Description: Galectin-1 is a member of the galectin family, and binds B-galactosidase moieties on glycoproteins or glycolipids. Galectins are primarily involved in modulation of cell-cell and cell-matrix interactions. Galectin-1 acts as a negative regulator of immunity, promoting immune suppression and lessening the inflammatory response. Galectin-1 binds CD45, CD3 and CD4, resulting in the inhibition of CD45 phosphatase dependant dephosphorylation of lyn kinase, as well as a number of other immune related receptors. Due to its function as a negative regulator of the immune response, and role inducing apoptosis in activated Th1 and Th17 cells, it is commonly found upregulated around malignant tumours. It has also been implicated as having a role in the development of immune tolerance during pregnancy, and is highly expressed at the maternal-fetal interface. As a dimer it down-regulates neutrophils by inducing exposure of phosphatidylserine, thereby marking the cell for apoptosis. It shares approximately 88% and 90% sequence similarity with mouse and rat galectin-1, respectively. Recombinant Human Galectin-1 is a 14.9kDa protein. |
|||
Recombinant Human Galectin-1 (LGALS1) |
|||
| Z101847 | ABM | 100 µg | EUR 270 |
|
Description: Galectin-1 is a member of the galectin family, and binds B-galactosidase moieties on glycoproteins or glycolipids. Galectins are primarily involved in modulation of cell-cell and cell-matrix interactions. Galectin-1 acts as a negative regulator of immunity, promoting immune suppression and lessening the inflammatory response. Galectin-1 binds CD45, CD3 and CD4, resulting in the inhibition of CD45 phosphatase dependant dephosphorylation of lyn kinase, as well as a number of other immune related receptors. Due to its function as a negative regulator of the immune response, and role inducing apoptosis in activated Th1 and Th17 cells, it is commonly found upregulated around malignant tumours. It has also been implicated as having a role in the development of immune tolerance during pregnancy, and is highly expressed at the maternal-fetal interface. As a dimer it down-regulates neutrophils by inducing exposure of phosphatidylserine, thereby marking the cell for apoptosis. It shares approximately 88% and 90% sequence similarity with mouse and rat galectin-1, respectively. Recombinant Human Galectin-1 is a 14.9kDa protein. |
|||
Recombinant Human Galectin-1 (LGALS1) |
|||
| Z101849 | ABM | 1.0 mg | EUR 1135 |
|
Description: Galectin-1 is a member of the galectin family, and binds B-galactosidase moieties on glycoproteins or glycolipids. Galectins are primarily involved in modulation of cell-cell and cell-matrix interactions. Galectin-1 acts as a negative regulator of immunity, promoting immune suppression and lessening the inflammatory response. Galectin-1 binds CD45, CD3 and CD4, resulting in the inhibition of CD45 phosphatase dependant dephosphorylation of lyn kinase, as well as a number of other immune related receptors. Due to its function as a negative regulator of the immune response, and role inducing apoptosis in activated Th1 and Th17 cells, it is commonly found upregulated around malignant tumours. It has also been implicated as having a role in the development of immune tolerance during pregnancy, and is highly expressed at the maternal-fetal interface. As a dimer it down-regulates neutrophils by inducing exposure of phosphatidylserine, thereby marking the cell for apoptosis. It shares approximately 88% and 90% sequence similarity with mouse and rat galectin-1, respectively. Recombinant Human Galectin-1 is a 14.9kDa protein. |
|||
Recombinant Human Galectin-1 (LGALS1) |
|||
| MBS7115230-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 255 |
Recombinant Human Galectin-1 (LGALS1) |
|||
| MBS7115230-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 405 |
Recombinant Human Galectin-1 (LGALS1) |
|||
| MBS7115230-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1425 |
Recombinant Human Galectin-1 (LGALS1) |
|||
| MBS7115230-5x1mgEColi | MyBiosource | 5x1mg(E-Coli) | EUR 6215 |
Recombinant Human Galectin-1 (LGALS1) |
|||
| MBS4159798-0015mg | MyBiosource | 0.015mg | EUR 255 |
Recombinant Human Galectin-1 (LGALS1) |
|||
| MBS4159798-01mg | MyBiosource | 0.1mg | EUR 430 |
Recombinant Human Galectin-1 (LGALS1) |
|||
| MBS4159798-1mg | MyBiosource | 1mg | EUR 1425 |
Recombinant Human Galectin-1 (LGALS1) |
|||
| MBS4159798-5x1mg | MyBiosource | 5x1mg | EUR 6165 |
Galectin-2， Human |
|||
| E34M149H | EnoGene | 5 μg | EUR 155 |
Galectin-3， Human |
|||
| E34M150H | EnoGene | 5 μg | EUR 155 |
Galectin-4， Human |
|||
| E34M151H | EnoGene | 5 μg | EUR 155 |
Galectin-7， Human |
|||
| E34M152H | EnoGene | 5 μg | EUR 155 |
Galectin-8， Human |
|||
| E34M153H | EnoGene | 5 μg | EUR 155 |
Galectin-9， Human |
|||
| E34M154H | EnoGene | 5 μg | EUR 155 |
Galectin-3 Human |
|||
| GWB-1FDCC0 | GenWay Biotech | 0.05 mg | Ask for price |
Galectin-2, Human |
|||
| MBS8575306-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-2, Human |
|||
| MBS8575306-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Galectin-3, Human |
|||
| MBS8575307-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-3, Human |
|||
| MBS8575307-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Galectin-4, Human |
|||
| MBS8575308-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-4, Human |
|||
| MBS8575308-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Galectin-7, Human |
|||
| MBS8575309-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-7, Human |
|||
| MBS8575309-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Galectin-8, Human |
|||
| MBS8575310-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-8, Human |
|||
| MBS8575310-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Galectin-9, Human |
|||
| MBS8575311-0005mg | MyBiosource | 0.005mg | EUR 245 |
Galectin-9, Human |
|||
| MBS8575311-5x0005mg | MyBiosource | 5x0.005mg | EUR 940 |
Human Galectin-1 Recombinant Protein |
|||
| 100-175 | ReliaTech | 50 µg | EUR 196.35 |
|
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues. |
|||
Human Galectin-1 Recombinant Protein |
|||
| 100-175S | ReliaTech | 10 µg | EUR 92.4 |
|
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues. |
|||
Human Galectin-1 Recombinant Protein |
|||
| 400-015 | ReliaTech | 50 µg | EUR 126 |
|
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with beta-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues. |
|||
Recombinant Human Galectin-1 Protein |
|||
| E40KMP1041 | EnoGene | 20ug | EUR 495 |
Recombinant Human Galectin-1 Protein |
|||
| PROTP09382-1 | BosterBio | 50ug | EUR 380.4 |
|
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues. |
|||
Recombinant Human Galectin-1 protein |
|||
| CD01752-10ug | Jiaxing Korain Biotech Ltd (BT Labs) | 10ug | EUR 176 |
|
Description: Human Galectin-1 also named BHL, Galaptin, GBP, L- 14 and LGALS1, is belonging to the galectins family and it is encoded by the LGALS1 gene in human. Galectin-1 is expressed by the endometrial stromal cells throughout the menstrual cycle. Galectin-1 contains a single carbohydrate recognition domain through which it can bind glycans both as a monomer and as a homodimer. Dimers are non-covenantly bound and will spontaneou sly disassociate in low concentration. Galectin -1 may act as an autocrine negative growth factor that regulates cell proliferation. Galectin - 1 is thought to play a role in the immunosuppression required for a successful pregnancy. Human Galectin-1 shares 88 %-90 % amino acid sequence identity with rat and mouse. |
|||
Recombinant Human Galectin-1 Protein |
|||
| MBS9139610-002mg | MyBiosource | 0.02mg | EUR 190 |
Recombinant Human Galectin-1 Protein |
|||
| MBS9139610-005mg | MyBiosource | 0.05mg | EUR 260 |
Recombinant Human Galectin-1 Protein |
|||
| MBS9139610-01mg | MyBiosource | 0.1mg | EUR 360 |
Recombinant Human Galectin-1 Protein |
|||
| MBS9139610-5x01mg | MyBiosource | 5x0.1mg | EUR 1445 |
Human Galectin-1 (Gal-1) Antibody (Biotin Conjugate) |
|||
| 30005-05121 | AssayPro | 150 ug | EUR 315 |
Human Galectin-1 ELISA ELISA Kit |
|||
| E16HE0311 | EnoGene | 96T | EUR 1000 |
Human Galectin 1 (LGALS1) Protein |
|||
| abx066725-100g | Abbexa | 100 µg | EUR 512.5 |
Human Galectin 1 (LGALS1) Protein |
|||
| abx066725-10g | Abbexa | 10 µg | EUR 212.5 |
Human Galectin 1 (LGALS1) Protein |
|||
| abx066725-50g | Abbexa | 50 µg | EUR 362.5 |
Human Galectin 1 (LGALS1) Protein |
|||
| abx670211-100g | Abbexa | 100 µg | EUR 450 |
Anti-Mouse Galectin-1 Antibody |
|||
| 103-M223 | ReliaTech | 100 µg | EUR 399 |
|
Description: The galectins constitute a large family of carbohydrate-binding proteins that function in many systems both intracellularly and following secretion. Galectins contain either one or two carbohydrate recognition domains (CRR) which mediate recognition of N-acetyl-lactosamine-containing glycoproteins. Some galectins exist in multiple isoforms due to alternative splicing. Individual galectins differ in their tissue distribution and in their carbohydrate-binding specificities. |
|||
Genetictesting for inherited retinal degenerations: Triumphs and tribulations
- Inherited retinal degenerations (IRDs) are a genotypically and phenotypically diverse group of conditions. Great strides have been made toward identifying the genetic basis for these conditions over the last 30 years-more than 270 different genes involved in syndromic and nonsyndromic forms of retinal dystrophies have now been identified.
- The identification of these genes and the improvement of clinical laboratory techniques have led to the identification of the genetic basis of disease in 56-76% of patients with IRDs through next generation sequencing and copy number variant analysis. Genetic testing is an essential part of clinical care for patients affected with IRDs and is required to confirm the diagnosis, understand the inheritance of the condition, and determine eligibility for gene-specific treatments or clinical trials.
- Despite the success achieved in determining the genetic cause of these conditions, several challenges remain, which must be considered when providing genetic testing and genetic counseling to patients. For this reason, an integrated team of ophthalmic and genetic clinicians who are familiar with these challenges is necessary to provide optimal comprehensive care to these patients.
A multicenter, prospective, blinded, nonselection study evaluating the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing-based preimplantation genetictesting for aneuploidy assay and impact of biopsy
Objective: To determine the predictive value of an aneuploid diagnosis with a targeted next-generation sequencing-based preimplantation genetic testing for aneuploidy (PGT-A) assay in prognosticating the failure of a successful delivery.
Design: Prospective, blinded, multicenter, nonselection study. All usable blastocysts were biopsied, and the single best morphologic blastocyst was transferred before genetic analysis. Preimplantation genetic testing for aneuploidy was performed after clinical outcome was determined. Clinical outcomes were compared to PGT-A results to calculate the predictive value of a PGT-A aneuploid diagnosis.
Setting: Fertility centers.
Patient(s): Couples undergoing their first in vitro fertilization cycle without recurrent pregnancy loss, antral follicle count < 8, or body mass index ≥ 35 kg/m2.
Intervention(s): None.
Main outcome measure(s): The primary outcome was the ability of the analytical result of aneuploid to predict failure to deliver (clinical result). A secondary outcome was the impact of the trophectoderm biopsy on sustained implantation.
Result(s): Four hundred two patients underwent 484 single, frozen, blastocyst transfers. The PGT-A aneuploid diagnosis clinical error rate was 0%. There was no difference in sustained implantation between the study group and an age-matched control group, where biopsy was not performed (47.9% vs. 45.8).
Conclusion(s): The PGT-A assay evaluated was highly prognostic of failure to deliver when an aneuploid result was obtained. Additionally, the trophectoderm biopsy had no detectable adverse impact on sustained implantation.
Mouse Anti Human Podoplanin |
|||
| MBS140296-5x01mg | MyBiosource | 5x0.1mg | EUR 2405 |
MOUSE ANTI HUMAN PODOPLANIN |
|||
| MBS212743-01mg | MyBiosource | 0.1mg | EUR 450 |
MOUSE ANTI HUMAN PODOPLANIN |
|||
| MBS212743-5x01mg | MyBiosource | 5x0.1mg | EUR 1840 |
Hamster anti Podoplanin (mouse) |
|||
| 103-M40 | Angio Proteomie | 100ug | EUR 297.6 |
Mouse Anti-Human Podoplanin |
|||
| MBS690117-0025mg | MyBiosource | 0.025mg | EUR 310 |
Mouse Anti-Human Podoplanin |
|||
| MBS690117-5x0025mg | MyBiosource | 5x0.025mg | EUR 1110 |
Mouse Anti-Human Podoplanin |
|||
| MBS690586-01mg | MyBiosource | 0.1mg | EUR 450 |
Mouse Anti-Human Podoplanin |
|||
| MBS690586-5x01mg | MyBiosource | 5x0.1mg | EUR 1725 |
Mouse Anti-Human Podoplanin |
|||
| MBS690680-0025mg | MyBiosource | 0.025mg | EUR 310 |
Mouse Anti-Human Podoplanin |
|||
| MBS690680-5x0025mg | MyBiosource | 5x0.025mg | EUR 1110 |
Mouse Anti-Human Podoplanin |
|||
| MBS690759-01mg | MyBiosource | 0.1mg | EUR 450 |
Mouse Anti-Human Podoplanin |
|||
| MBS690759-5x01mg | MyBiosource | 5x0.1mg | EUR 1725 |
Mouse Anti-Human Podoplanin |
|||
| MBS690992-005mg | MyBiosource | 0.05mg | EUR 430 |
Mouse Anti-Human Podoplanin |
|||
| MBS690992-5x005mg | MyBiosource | 5x0.05mg | EUR 1645 |
Mouse Anti-Human Podoplanin |
|||
| MBS692357-005mg | MyBiosource | 0.05mg | EUR 450 |
Mouse Anti-Human Podoplanin |
|||
| MBS692357-5x005mg | MyBiosource | 5x0.05mg | EUR 1725 |
Mouse Anti-Human Podoplanin |
|||
| MBS692358-005mg | MyBiosource | 0.05mg | EUR 450 |
Mouse Anti-Human Podoplanin |
|||
| MBS692358-5x005mg | MyBiosource | 5x0.05mg | EUR 1725 |
Mouse anti Podoplanin-Biotin (human) |
|||
| 101-MBi40 | Angio Proteomie | 50ug | EUR 297.6 |
Hamster anti Podoplanin-Biotin (mouse) |
|||
| 103-MBi40 | Angio Proteomie | 50ug | EUR 297.6 |
Podoplanin Mouse mAb |
|||
| A18776 | Abclonal | 100μL | EUR 719.13 |
Mouse Anti Human Podoplanin clone P56F7AT |
|||
| MBS146676-0005mg | MyBiosource | 0.005mg | EUR 240 |
Mouse Anti Human Podoplanin clone P56F7AT |
|||
| MBS146676-002mg | MyBiosource | 0.02mg | EUR 310 |
Mouse Anti Human Podoplanin clone P56F7AT |
|||
| MBS146676-01mg | MyBiosource | 0.1mg | EUR 610 |
Mouse Anti Human Podoplanin clone P56F7AT |
|||
| MBS146676-5x01mg | MyBiosource | 5x0.1mg | EUR 2405 |
Mouse Podoplanin, soluble |
|||
| MBS691731-0005mg | MyBiosource | 0.005mg | EUR 250 |
Mouse Podoplanin, soluble |
|||
| MBS691731-5x0005mg | MyBiosource | 5x0.005mg | EUR 835 |
Anti-Human/Mouse PDPN/Podoplanin Antibody |
|||
| MBS1569238-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-Human/Mouse PDPN/Podoplanin Antibody |
|||
| MBS1569238-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Recombinant Mouse Podoplanin |
|||
| MBS7610672-005mg | MyBiosource | 0.05mg | EUR 345 |
Recombinant Mouse Podoplanin |
|||
| MBS7610672-02mg | MyBiosource | 0.2mg | EUR 635 |
Recombinant Mouse Podoplanin |
|||
| MBS7610672-1mg | MyBiosource | 1mg | EUR 1800 |
Recombinant Mouse Podoplanin |
|||
| MBS7610672-5x1mg | MyBiosource | 5x1mg | EUR 6955 |
Mouse Monoclonal anti-Rat Podoplanin Antibody |
|||
| xAP-0897 | Angio Proteomie | 100ug | EUR 280 |
Mouse Podoplanin ELISA kit |
|||
| E01A24381 | BlueGene | 96T | EUR 700 |
|
Description: ELISA |
|||
Mouse Podoplanin ELISA kit |
|||
| E03P0082-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse Podoplanin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Podoplanin ELISA kit |
|||
| E03P0082-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse Podoplanin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Podoplanin ELISA kit |
|||
| E03P0082-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse Podoplanin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Podoplanin ELISA Kit |
|||
| IMSPDPNKT | Innovative research | each | EUR 752 |
|
Description: Mouse Podoplanin ELISA Kit |
|||
Mouse Podoplanin ELISA Kit |
|||
| MBS725552-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 5685 |
Mouse Podoplanin ELISA Kit |
|||
| MBS725552-48StripWells | MyBiosource | 48-Strip-Wells | EUR 485 |
Mouse Podoplanin ELISA Kit |
|||
| MBS725552-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3020 |
Mouse Podoplanin ELISA Kit |
|||
| MBS725552-96StripWells | MyBiosource | 96-Strip-Wells | EUR 690 |
Mouse Podoplanin ELISA Kit |
|||
| MBS2884556-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 4080 |
Mouse Podoplanin ELISA Kit |
|||
| MBS2884556-48StripWells | MyBiosource | 48-Strip-Wells | EUR 390 |
Mouse Podoplanin ELISA Kit |
|||
| MBS2884556-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2220 |
Mouse Podoplanin ELISA Kit |
|||
| MBS2884556-96StripWells | MyBiosource | 96-Strip-Wells | EUR 520 |
Hamster Anti-Mouse Podoplanin |
|||
| MBS690646-01mg | MyBiosource | 0.1mg | EUR 450 |
Hamster Anti-Mouse Podoplanin |
|||
| MBS690646-5x01mg | MyBiosource | 5x0.1mg | EUR 1725 |
Hamster Anti-Mouse Podoplanin |
|||
| MBS690790-005mg | MyBiosource | 0.05mg | EUR 430 |
Hamster Anti-Mouse Podoplanin |
|||
| MBS690790-5x005mg | MyBiosource | 5x0.05mg | EUR 1645 |
Anti-Mouse Podoplanin Antibody |
|||
| 103-M552 | ReliaTech | 100 µg | EUR 399 |
|
Description: Podoplanin, also known as glycoprotein 38 (gp38), PA2.26 antigen, T1alpha (T1A), and aggrus, is a 38 kDa type I transmembrane sialoglycoprotein and member of the podoplanin family. Podoplanin is synthesized as a 172 amino acid (aa) precursor with a 22 aa signal sequence, a 119 aa extracellular domain (ECD), a 21 aa transmembrane region, and a short, 10 aa cytoplasmic tail. The ECD contains abundant Ser/Thr residues as potential sites for Oglycosylation, and the cytoplasmic region contains putative sites for kinase C and cAMP phosphorylation. Mouse Podoplanin shares 77% and 46% aa sequence identity with rat and human Podoplanin, respectively. Podoplanin is expressed on glomerular epithelial cells (podocytes), type I lung alveolar cells, lymphatic endothelial cells, and on numerous tumors including colorectal tumors, squamous cell carcinomas, testicular seminoma, and brain tumors. One study shows high expression of Podoplanin mRNA in placenta, lung, skeletal muscle, and heart, and weaker levels in brain, kidney, and liver. Podoplanin is the ligand for Ctype lectin like receptor 2 (CLEC2). Their association is dependent on sialic acid on Oglycans of Podoplanin. Through its association with CLEC2, Podoplanin induces platelet aggregation and tumor metastasis. Podoplanin is also necessary for lymphatic vessel formation, normal lung cell proliferation and alveolus formation at birth. |
|||
Anti-Mouse Podoplanin Antibody |
|||
| 103-PA40 | ReliaTech | 200 µg | EUR 204.75 |
|
Description: Podoplanin, also known as glycoprotein 38 (gp38), PA2.26 antigen, T1alpha (T1A), and aggrus, is a 38 kDa type I transmembrane sialoglycoprotein and member of the podoplanin family. Podoplanin is synthesized as a 172 amino acid (aa) precursor with a 22 aa signal sequence, a 119 aa extracellular domain (ECD), a 21 aa transmembrane region, and a short, 10 aa cytoplasmic tail. The ECD contains abundant Ser/Thr residues as potential sites for Oglycosylation, and the cytoplasmic region contains putative sites for kinase C and cAMP phosphorylation. Mouse Podoplanin shares 77% and 46% aa sequence identity with rat and human Podoplanin, respectively. Podoplanin is expressed on glomerular epithelial cells (podocytes), type I lung alveolar cells, lymphatic endothelial cells, and on numerous tumors including colorectal tumors, squamous cell carcinomas, testicular seminoma, and brain tumors. One study shows high expression of Podoplanin mRNA in placenta, lung, skeletal muscle, and heart, and weaker levels in brain, kidney, and liver. Podoplanin is the ligand for Ctype lectin like receptor 2 (CLEC2). Their association is dependent on sialic acid on Oglycans of Podoplanin. Podoplanin is also necessary for lymphatic vessel formation, normal lung cell proliferation and alveolus formation at birth. |
|||
Anti-Mouse Podoplanin Antibody |
|||
| 103-PA40S | ReliaTech | 100 µg | EUR 126 |
|
Description: Podoplanin, also known as glycoprotein 38 (gp38), PA2.26 antigen, T1alpha (T1A), and aggrus, is a 38 kDa type I transmembrane sialoglycoprotein and member of the podoplanin family. Podoplanin is synthesized as a 172 amino acid (aa) precursor with a 22 aa signal sequence, a 119 aa extracellular domain (ECD), a 21 aa transmembrane region, and a short, 10 aa cytoplasmic tail. The ECD contains abundant Ser/Thr residues as potential sites for Oglycosylation, and the cytoplasmic region contains putative sites for kinase C and cAMP phosphorylation. Mouse Podoplanin shares 77% and 46% aa sequence identity with rat and human Podoplanin, respectively. Podoplanin is expressed on glomerular epithelial cells (podocytes), type I lung alveolar cells, lymphatic endothelial cells, and on numerous tumors including colorectal tumors, squamous cell carcinomas, testicular seminoma, and brain tumors. One study shows high expression of Podoplanin mRNA in placenta, lung, skeletal muscle, and heart, and weaker levels in brain, kidney, and liver. Podoplanin is the ligand for Ctype lectin like receptor 2 (CLEC2). Their association is dependent on sialic acid on Oglycans of Podoplanin. Podoplanin is also necessary for lymphatic vessel formation, normal lung cell proliferation and alveolus formation at birth. |
|||
Mouse Podoplanin (PDPN) Protein |
|||
| 20-abx650139 | Abbexa |
|
|
Mouse Podoplanin (PDPN) Protein |
|||
| abx694266-10nmol | Abbexa | 10 nmol | EUR 700 |
Mouse Podoplanin (PDPN) Protein |
|||
| abx694266-5nmol | Abbexa | 5 nmol | EUR 462.5 |
Mouse Podoplanin (PDPN) Protein |
|||
| abx650139-100g | Abbexa | 100 µg | EUR 537.5 |
Mouse Podoplanin (PDPN) Protein |
|||
| abx650139-10g | Abbexa | 10 µg | EUR 212.5 |
Mouse Podoplanin (PDPN) Protein |
|||
| abx650139-50g | Abbexa | 50 µg | EUR 375 |
Podoplanin (ABT513) Mouse mAb |
|||
| UB-GEN-14883 | UpingBio | 100 ul | EUR 200 |
Podoplanin (ABT360) Mouse mAb |
|||
| UB-GEN-15155 | UpingBio | 100 ul | EUR 200 |
Mouse Monoclonal Podoplanin Antibody |
|||
| TA327727 | Origene Technologies GmbH | 1 ml | Ask for price |
anti- Podoplanin antibody |
|||
| FNab06598 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against Podoplanin |
|||
anti- Podoplanin antibody |
|||
| FNab06599 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against Podoplanin |
|||
Mouse Podoplanin (PDPN) CLIA Kit |
|||
| 20-abx493858 | Abbexa |
|
|
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| abx571749-96tests | Abbexa | 96 tests | EUR 943.2 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| 20-abx154564 | Abbexa |
|
|
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| DLR-PDPN-Mu | DL Develop | 96T | EUR 475 |
|
Description: tissue homogenates, cell lysates or other biological fluids. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| DLR-PDPN-Mu-48T | DL Develop | 48T | EUR 632.4 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Podoplanin (PDPN) in samples from tissue homogenates, cell lysates or other biological fluids. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| DLR-PDPN-Mu-96T | DL Develop | 96T | EUR 825.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Podoplanin (PDPN) in samples from tissue homogenates, cell lysates or other biological fluids. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| DL-PDPN-Mu | DL Develop | 96T | EUR 453 |
|
Description: tissue homogenates, cell lysates or other biological fluids. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| EK8596 | SAB | 96Т | EUR 799 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| EKN47838-48T | Biomatik Corporation | 48T | EUR 389.62 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| EKN47838-5x96T | Biomatik Corporation | 5x96T | EUR 2643.85 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| EKN47838-96T | Biomatik Corporation | 96T | EUR 556.6 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| AE28131MO-48Tests | Abebio | 48 Tests | EUR 325 |
|
Description: Mouse (Mus musculus) |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| AE28131MO-96Tests | Abebio | 96 Tests | EUR 610 |
|
Description: Mouse (Mus musculus) |
|||
Mouse Podoplanin (PDPN)ELISA kit |
|||
| YLA0596MO-48T | Shanghai YL Biotech | 48T | Ask for price |
Mouse Podoplanin (PDPN)ELISA kit |
|||
| YLA0596MO-96T | Shanghai YL Biotech | 96T | Ask for price |
Mouse Podoplanin, Pdpn ELISA KIT |
|||
| ELI-06723m | Nova Lifetech | 96tests | EUR 736 |
Mouse Podoplanin,PDPN ELISA KIT |
|||
| E1437Mo-1096T | Jiaxing Korain Biotech Ltd (BT Labs) | 10*96T | EUR 4122 |
Mouse Podoplanin,PDPN ELISA KIT |
|||
| E1437Mo-48wells | Jiaxing Korain Biotech Ltd (BT Labs) | 48 wells | EUR 300 |
Mouse Podoplanin,PDPN ELISA KIT |
|||
| E1437Mo-596T | Jiaxing Korain Biotech Ltd (BT Labs) | 5*96T | EUR 2061 |
Mouse Podoplanin,PDPN ELISA KIT |
|||
| E1437Mo-96wells | Jiaxing Korain Biotech Ltd (BT Labs) | 96 wells | EUR 458 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| EKU06727-48T | Biomatik Corporation | 48T | EUR 571.55 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| EKU06727-5x96T | Biomatik Corporation | 5x96T | EUR 3878.38 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| EKU06727-96T | Biomatik Corporation | 96T | EUR 816.5 |
Mouse Podoplanin(PDPN)ELISA kit |
|||
| QY-E21215 | Qayee Biotechnology | 96T | EUR 433.2 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| RK13459 | Abclonal | 96T | EUR 280 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| RDR-PDPN-Mu-48T | Reddot Biotech | 48T | EUR 487.52 |
|
Description: tissue homogenates, cell lysates and other biological fluids. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| RDR-PDPN-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 668.4 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| RDR-PDPN-Mu-96T | Reddot Biotech | 96T | EUR 696.47 |
|
Description: tissue homogenates, cell lysates and other biological fluids. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| RDR-PDPN-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 928.8 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| RD-PDPN-Mu-48T | Reddot Biotech | 48T | EUR 464.3 |
|
Description: tissue homogenates, cell lysates and other biological fluids. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| RD-PDPN-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 639.6 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| RD-PDPN-Mu-96T | Reddot Biotech | 96T | EUR 663.3 |
|
Description: tissue homogenates, cell lysates and other biological fluids. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| RD-PDPN-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 888 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| SEC719Mu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 5834.88 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Podoplanin (PDPN) in tissue homogenates, cell lysates and other biological fluids. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| SEC719Mu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 585.7 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Podoplanin (PDPN) in tissue homogenates, cell lysates and other biological fluids. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| SEC719Mu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 785.28 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Podoplanin (PDPN) in tissue homogenates, cell lysates and other biological fluids. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| SEC719Mu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 3173.76 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Podoplanin (PDPN) in tissue homogenates, cell lysates and other biological fluids. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| 4-SEC719Mu | Cloud-Clone |
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Podoplanin (PDPN) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| AE28131MO-48T | Abebio | 48T | EUR 325 |
|
Description: Mouse (Mus musculus) |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| AE28131MO-96T | Abebio | 96T | EUR 610 |
|
Description: Mouse (Mus musculus) |
|||
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS9309796-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS9309796-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS9309796-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS9309796-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS1601033-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3955 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS1601033-48StripWells | MyBiosource | 48-Strip-Wells | EUR 305 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS1601033-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2005 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS1601033-96StripWells | MyBiosource | 96-Strip-Wells | EUR 475 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2020020-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 5455 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2020020-24StripWells | MyBiosource | 24-Strip-Wells | EUR 365 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2020020-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2020020-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2985 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2020020-96StripWells | MyBiosource | 96-Strip-Wells | EUR 740 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS4501762-10x96Tests | MyBiosource | 10x96Tests | EUR 5375 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS4501762-48Tests | MyBiosource | 48Tests | EUR 470 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS4501762-5x96Tests | MyBiosource | 5x96Tests | EUR 2755 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS4501762-96Test | MyBiosource | 96Test | EUR 620 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2803565-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6255 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2803565-48StripWells | MyBiosource | 48-Strip-Wells | EUR 445 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2803565-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3290 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2803565-96StripWells | MyBiosource | 96-Strip-Wells | EUR 730 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS455766-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 5160 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS455766-48StripWells | MyBiosource | 48-Strip-Wells | EUR 450 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS455766-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2645 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS455766-96StripWells | MyBiosource | 96-Strip-Wells | EUR 595 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2704635-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3215 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2704635-24StripWells | MyBiosource | 24-Strip-Wells | EUR 255 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2704635-48StripWells | MyBiosource | 48-Strip-Wells | EUR 340 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2704635-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1675 |
Mouse Podoplanin (PDPN) ELISA Kit |
|||
| MBS2704635-96StripWells | MyBiosource | 96-Strip-Wells | EUR 430 |
Recombinant Mouse Podoplanin Protein |
|||
| MBS8305318-001mg | MyBiosource | 0.01mg | EUR 220 |
Recombinant Mouse Podoplanin Protein |
|||
| MBS8305318-005mg | MyBiosource | 0.05mg | EUR 450 |
Recombinant Mouse Podoplanin Protein |
|||
| MBS8305318-05mg | MyBiosource | 0.5mg | EUR 1905 |
Recombinant Mouse Podoplanin Protein |
|||
| MBS8305318-5x05mg | MyBiosource | 5x0.5mg | EUR 8485 |
Mouse PDPN (Podoplanin) ELISA Kit |
|||
| EKE61859-5x96T | Biomatik Corporation | 5x96T | EUR 3124.08 |
Mouse PDPN (Podoplanin) ELISA Kit |
|||
| EKE61859-96T | Biomatik Corporation | 96T | EUR 657.7 |
Mouse PDPN(Podoplanin) ELISA Kit |
|||
| ELK7080-48T | ELK Biotech | 48T | Ask for price |
|
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Mouse PDPN. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Mouse PDPN. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Mouse PDPN, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Mouse PDPN in the samples is then determined by comparing the OD of the samples to the standard curve. |
|||
Mouse PDPN(Podoplanin) ELISA Kit |
|||
| ELK7080-96T | ELK Biotech | 96T | Ask for price |
|
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Mouse PDPN. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Mouse PDPN. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Mouse PDPN, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Mouse PDPN in the samples is then determined by comparing the OD of the samples to the standard curve. |
|||
Mouse PDPN(Podoplanin) ELISA Kit |
|||
| RE2052M-48wells | Reed Biotech | 48 wells | EUR 116.55 |
Mouse PDPN(Podoplanin) ELISA Kit |
|||
| RE2052M-96wells | Reed Biotech | 96 wells | EUR 161.55 |
Mouse Pdpn / Podoplanin ELISA Kit |
|||
| E2095m | EIAab | 96T | EUR 776 |
Mouse PDPN (Podoplanin) ELISA Kit |
|||
| MBS8806057-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 3130 |
Mouse PDPN (Podoplanin) ELISA Kit |
|||
| MBS8806057-48StripWells | MyBiosource | 48-Strip-Wells | EUR 350 |
Mouse PDPN (Podoplanin) ELISA Kit |
|||
| MBS8806057-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1710 |
Mouse PDPN (Podoplanin) ELISA Kit |
|||
| MBS8806057-96StripWells | MyBiosource | 96-Strip-Wells | EUR 445 |
Mouse PDPN (Podoplanin) ELISA Kit |
|||
| MBS2516017-10x96Tests | MyBiosource | 10x96Tests | EUR 4060 |
Mouse PDPN (Podoplanin) ELISA Kit |
|||
| MBS2516017-24Tests | MyBiosource | 24Tests | EUR 265 |
Mouse PDPN (Podoplanin) ELISA Kit |
|||
| MBS2516017-48Test | MyBiosource | 48Test | EUR 450 |
Mouse PDPN (Podoplanin) ELISA Kit |
|||
| MBS2516017-5x96Test | MyBiosource | 5x96Test | EUR 2265 |
Mouse PDPN (Podoplanin) ELISA Kit |
|||
| MBS2516017-96Tests | MyBiosource | 96Tests | EUR 535 |
Mouse PDPN(Podoplanin) ELISA Kit |
|||
| RE2052M-48wellsplate | Reed Biotech | 48-wells plate | EUR 126 |
Mouse PDPN(Podoplanin) ELISA Kit |
|||
| RE2052M-96wellsplate | Reed Biotech | 96-wells plate | EUR 180 |
Recombinant Mouse Podoplanin (C-Fc) |
|||
| CU73-10ug | Novoprotein | 10ug | EUR 157.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse Podoplanin (C-Fc) |
|||
| CU73-1mg | Novoprotein | 1mg | EUR 2008.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse Podoplanin (C-Fc) |
|||
| CU73-500ug | Novoprotein | 500ug | EUR 1399.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse Podoplanin (C-Fc) |
|||
| CU73-50ug | Novoprotein | 50ug | EUR 327.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Mouse Podoplanin, PDPN GENLISA ELISA |
|||
| KLM1437 | Krishgen | 1 x 96 wells | EUR 341 |
Podoplanin (PDPN) Polyclonal Antibody (Mouse) |
|||
| 4-PAC719Mu01 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Podoplanin (PDPN) |
|||
ELISA kit for Mouse Podoplanin (PDPN) |
|||
| KTE70775-48T | Abbkine | 48T | EUR 398.4 |
|
Description: Quantitative sandwich ELISA for measuring Mouse Podoplanin (PDPN) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Mouse Podoplanin (PDPN) |
|||
| KTE70775-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 2538 |
|
Description: Quantitative sandwich ELISA for measuring Mouse Podoplanin (PDPN) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Mouse Podoplanin (PDPN) |
|||
| KTE70775-96T | Abbkine | 96T | EUR 646.8 |
|
Description: Quantitative sandwich ELISA for measuring Mouse Podoplanin (PDPN) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
Hamster Monoclonal anti-mouse Podoplanin |
|||
| mAP-0062 | Angio Proteomie | 100ug | EUR 250 |
Anti-Rat Podoplanin Antibody |
|||
| 104-M40 | ReliaTech | 100 µg | EUR 189 |
|
Description: Podoplanin is a well-recognized lymphatic endothelium marker, which can be used to reliably distinguish lymphatic vessels from blood vessels. It was originally discovered in kidney podocytes. This mouse monoclonal antibody (IgG) against rat podoplanin works well for immunohistochemistry with formalin-fixed paraffin embedded sections. This antibody also can be used in FACS sorting. |
|||
Anti- Podoplanin Human Antibody |
|||
| GWB-F131C7 | GenWay Biotech | 0.2 mg | Ask for price |
ELISA kit for Mouse PDPN (Podoplanin) |
|||
| E-EL-M2409 | Elabscience Biotech | 1 plate of 96 wells | EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Mouse PDPN (Podoplanin) in samples from Serum, Plasma, Cell supernatant |
|||
ELISA kit for Mouse PDPN (Podoplanin) |
|||
| ELK7080 | ELK Biotech | 1 plate of 96 wells | EUR 518.4 |
|
Description: A sandwich ELISA kit for detection of Podoplanin from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Podoplanin (PDPN) Polyclonal Antibody (Mouse), PE |
|||
| 4-PAC719Mu01-PE | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Podoplanin (PDPN). This antibody is labeled with PE. |
|||
Rabbit Anti-Human Podoplanin |
|||
| 102-PA40 | Angio Proteomie | 100ug | EUR 240 |
Recombinant Mouse Podoplanin (Pdpn), partial |
|||
| MBS1362245-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 990 |
Recombinant Mouse Podoplanin (Pdpn), partial |
|||
| MBS1362245-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | EUR 1215 |
Recombinant Mouse Podoplanin (Pdpn), partial |
|||
| MBS1362245-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 990 |
Recombinant Mouse Podoplanin (Pdpn), partial |
|||
| MBS1362245-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1215 |
Recombinant Mouse Podoplanin (Pdpn), partial |
|||
| MBS1362245-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1390 |
Mouse Anti-Human Podoplanin monoclonal antibody, clone JID761 |
|||
| CABT-L2919-100uL500uL | Creative Diagnostics | 100 uL, 500 uL | EUR 602.4 |
Mouse Anti-Human Podoplanin monoclonal antibody, clone JID761 |
|||
| CABT-L2919 | Creative Diagnostics | 100 µl, 500 µl | Ask for price |
|
Description: Mouse |
|||
Anti-Human Podoplanin Antibody |
|||
| 101-M40-FITC | ReliaTech | 50 µg | Ask for price |
|
Description: Podoplanin, also known as glycoprotein 36 (gp36), PA2.26 antigen, T1alpha (T1A), and aggrus, is a 36 kDa type I transmembrane sialoglycoprotein and member of the Podoplanin family. Podoplanin has three potential splice variants, the longest of which is represented by a 238 amino acid (aa) precursor (NP_006465). It contains an undefined signal sequence, a 22 aa transmembrane segment (aa 207228) and a short cytoplasmic tail (aa 229-238). The ECD contains abundant Ser/Thr residues that could serve as potential Olinked glycosolation sites. The cytoplasmic tail contains putative sites for protein kinase C phosphorylation. There are two potential alternate start sites at Met 77 (Swiss Prot #: Q86YL7) and Met 119 (EAW51692) that generate short forms. The 162 aa short form Podoplanin precursor shares 47% aa identity with mouse Podoplanin. Podoplanin is expressed on glomerular epithelial cells (podocytes), type I lung alveolar cells, lymphatic endothelial cells, and numerous tumors, including colorectal tumors, squamous cell carcinomas, testicular seminoma, and brain tumors. One study shows high expression of Podoplanin mRNA in placenta, lung, skeletal muscle, and heart, and weaker levels in brain, kidney, and liver. Podoplanin is the ligand for Ctype lectin-like receptor 2 (CLEC2). Their association is dependent on sialic acid on Oglycans of Podoplanin. Through its association with CLEC2, Podoplanin-induces platelet aggregation and tumor metastasis. Podoplanin is also necessary for lymphatic vessel formation, normal lung cell proliferation and alveolus formation at birth. |
|||
Anti-Human Podoplanin Antibody |
|||
| 101-M40-PE | ReliaTech | 50 µg | Ask for price |
|
Description: Podoplanin, also known as glycoprotein 36 (gp36), PA2.26 antigen, T1alpha (T1A), and aggrus, is a 36 kDa type I transmembrane sialoglycoprotein and member of the Podoplanin family. Podoplanin has three potential splice variants, the longest of which is represented by a 238 amino acid (aa) precursor (NP_006465). It contains an undefined signal sequence, a 22 aa transmembrane segment (aa 207228) and a short cytoplasmic tail (aa 229-238). The ECD contains abundant Ser/Thr residues that could serve as potential Olinked glycosolation sites. The cytoplasmic tail contains putative sites for protein kinase C phosphorylation. There are two potential alternate start sites at Met 77 (Swiss Prot #: Q86YL7) and Met 119 (EAW51692) that generate short forms. The 162 aa short form Podoplanin precursor shares 47% aa identity with mouse Podoplanin. Podoplanin is expressed on glomerular epithelial cells (podocytes), type I lung alveolar cells, lymphatic endothelial cells, and numerous tumors, including colorectal tumors, squamous cell carcinomas, testicular seminoma, and brain tumors. One study shows high expression of Podoplanin mRNA in placenta, lung, skeletal muscle, and heart, and weaker levels in brain, kidney, and liver. Podoplanin is the ligand for Ctype lectin-like receptor 2 (CLEC2). Their association is dependent on sialic acid on Oglycans of Podoplanin. Through its association with CLEC2, Podoplanin-induces platelet aggregation and tumor metastasis. Podoplanin is also necessary for lymphatic vessel formation, normal lung cell proliferation and alveolus formation at birth. |
|||
Anti-Human Podoplanin Antibody |
|||
| 101-M40S-FITC | ReliaTech | 25 µg | Ask for price |
|
Description: Podoplanin, also known as glycoprotein 36 (gp36), PA2.26 antigen, T1alpha (T1A), and aggrus, is a 36 kDa type I transmembrane sialoglycoprotein and member of the Podoplanin family. Podoplanin has three potential splice variants, the longest of which is represented by a 238 amino acid (aa) precursor (NP_006465). It contains an undefined signal sequence, a 22 aa transmembrane segment (aa 207228) and a short cytoplasmic tail (aa 229-238). The ECD contains abundant Ser/Thr residues that could serve as potential Olinked glycosolation sites. The cytoplasmic tail contains putative sites for protein kinase C phosphorylation. There are two potential alternate start sites at Met 77 (Swiss Prot #: Q86YL7) and Met 119 (EAW51692) that generate short forms. The 162 aa short form Podoplanin precursor shares 47% aa identity with mouse Podoplanin. Podoplanin is expressed on glomerular epithelial cells (podocytes), type I lung alveolar cells, lymphatic endothelial cells, and numerous tumors, including colorectal tumors, squamous cell carcinomas, testicular seminoma, and brain tumors. One study shows high expression of Podoplanin mRNA in placenta, lung, skeletal muscle, and heart, and weaker levels in brain, kidney, and liver. Podoplanin is the ligand for Ctype lectin-like receptor 2 (CLEC2). Their association is dependent on sialic acid on Oglycans of Podoplanin. Through its association with CLEC2, Podoplanin-induces platelet aggregation and tumor metastasis. Podoplanin is also necessary for lymphatic vessel formation, normal lung cell proliferation and alveolus formation at birth. |
|||
Anti-Human Podoplanin Antibody |
|||
| 101-M40S-PE | ReliaTech | 25 µg | Ask for price |
|
Description: Podoplanin, also known as glycoprotein 36 (gp36), PA2.26 antigen, T1alpha (T1A), and aggrus, is a 36 kDa type I transmembrane sialoglycoprotein and member of the Podoplanin family. Podoplanin has three potential splice variants, the longest of which is represented by a 238 amino acid (aa) precursor (NP_006465). It contains an undefined signal sequence, a 22 aa transmembrane segment (aa 207228) and a short cytoplasmic tail (aa 229-238). The ECD contains abundant Ser/Thr residues that could serve as potential Olinked glycosolation sites. The cytoplasmic tail contains putative sites for protein kinase C phosphorylation. There are two potential alternate start sites at Met 77 (Swiss Prot #: Q86YL7) and Met 119 (EAW51692) that generate short forms. The 162 aa short form Podoplanin precursor shares 47% aa identity with mouse Podoplanin. Podoplanin is expressed on glomerular epithelial cells (podocytes), type I lung alveolar cells, lymphatic endothelial cells, and numerous tumors, including colorectal tumors, squamous cell carcinomas, testicular seminoma, and brain tumors. One study shows high expression of Podoplanin mRNA in placenta, lung, skeletal muscle, and heart, and weaker levels in brain, kidney, and liver. Podoplanin is the ligand for Ctype lectin-like receptor 2 (CLEC2). Their association is dependent on sialic acid on Oglycans of Podoplanin. Through its association with CLEC2, Podoplanin-induces platelet aggregation and tumor metastasis. Podoplanin is also necessary for lymphatic vessel formation, normal lung cell proliferation and alveolus formation at birth. |
|||
Anti-Human Podoplanin Antibody |
|||
| 101-M41 | ReliaTech | 100 µg | EUR 199.5 |
|
Description: Podoplanin, also known as glycoprotein 36 (gp36), PA2.26 antigen, T1alpha (T1A), and aggrus, is a 36 kDa type I transmembrane sialoglycoprotein and member of the Podoplanin family. Podoplanin has three potential splice variants, the longest of which is represented by a 238 amino acid (aa) precursor (NP_006465). It contains an undefined signal sequence, a 22 aa transmembrane segment (aa 207-228) and a short cytoplasmic tail (aa 229-238). The ECD contains abundant Ser/Thr residues that could serve as potential O-linked glycosolation sites. The cytoplasmic tail contains putative sites for protein kinase C phosphorylation. There are two potential alternate start sites at Met 77 (Swiss Prot #: Q86YL7) and Met 119 (EAW51692) that generate short forms. The 162 aa short form Podoplanin precursor shares 47% aa identity with mouse Podoplanin. Podoplanin is expressed on glomerular epithelial cells (podocytes), type I lung alveolar cells, lymphatic endothelial cells, and numerous tumors, including colorectal tumors, squamous cell carcinomas, testicular seminoma, and brain tumors. One study shows high expression of Podoplanin mRNA in placenta, lung, skeletal muscle, and heart, and weaker levels in brain, kidney, and liver. Podoplanin is the ligand for C-type lectin-like receptor 2 (CLEC2). Their association is dependent on sialic acid on O-glycans of Podoplanin. Through its association with CLEC2, Podoplanin-induces platelet aggregation and tumor metastasis. Podoplanin is also necessary for lymphatic vessel formation, normal lung cell proliferation and alveolus formation at birth. |
|||
Anti-Human Podoplanin Antibody |
|||
| 102-PA40AG | ReliaTech | 50 µg | EUR 147 |
|
Description: Podoplanin, also known as glycoprotein 36 (gp36), PA2.26 antigen, T1alpha (T1A), and aggrus, is a 36 kDa type I transmembrane sialoglycoprotein and member of the Podoplanin family. Podoplanin has three potential splice variants, the longest of which is represented by a 238 amino acid (aa) precursor (NP_006465). It contains an undefined signal sequence, a 22 aa transmembrane segment (aa 207-228) and a short cytoplasmic tail (aa 229-238). The ECD contains abundant Ser/Thr residues that could serve as potential Olinked glycosolation sites. The cytoplasmic tail contains putative sites for protein kinase C phosphorylation. There are two potential alternate start sites at Met 77 (Swiss Prot #: Q86YL7) and Met 119 (EAW51692) that generate short forms. The 162 aa short form Podoplanin precursor shares 47% aa identity with mouse Podoplanin. Podoplanin is expressed on glomerular epithelial cells (podocytes), type I lung alveolar cells, lymphatic endothelial cells, and numerous tumors, including colorectal tumors, squamous cell carcinomas, testicular seminoma, and brain tumors. One study shows high expression of Podoplanin mRNA in placenta, lung, skeletal muscle, and heart, and weaker levels in brain, kidney, and liver (1). Podoplanin is the ligand for Ctype lectin-like receptor 2 (CLEC2). Their association is dependent on sialic acid on Oglycans of Podoplanin. Through its association with CLEC2, Podoplanin induces platelet aggregation and tumor metastasis. Podoplanin is also necessary for lymphatic vessel formation, normal lung cell proliferation and alveolus formation at birth. |
|||
Anti-Human Podoplanin Antibody |
|||
| 102-PA40S | ReliaTech | 100 µg | EUR 126 |
|
Description: Podoplanin, also known as glycoprotein 36 (gp36), PA2.26 antigen, T1alpha (T1A), and aggrus, is a 36 kDa type I transmembrane sialoglycoprotein and member of the Podoplanin family. Podoplanin has three potential splice variants, the longest of which is represented by a 238 amino acid (aa) precursor (NP_006465). It contains an undefined signal sequence, a 22 aa transmembrane segment (aa 207-228) and a short cytoplasmic tail (aa 229-238). The ECD contains abundant Ser/Thr residues that could serve as potential O-linked glycosolation sites. The cytoplasmic tail contains putative sites for protein kinase C phosphorylation. There are two potential alternate start sites at Met 77 (Swiss Prot #: Q86YL7) and Met 119 (EAW51692) that generate short forms. The 162 aa short form Podoplanin precursor shares 47% aa identity with mouse Podoplanin. Podoplanin is expressed on glomerular epithelial cells (podocytes), type I lung alveolar cells, lymphatic endothelial cells, and numerous tumors, including colorectal tumors, squamous cell carcinomas, testicular seminoma, and brain tumors. One study shows high expression of Podoplanin mRNA in placenta, lung, skeletal muscle, and heart, and weaker levels in brain, kidney, and liver. Podoplanin is the ligand for C-type lectin-like receptor 2 (CLEC2). Their association is dependent on sialic acid on O-glycans of Podoplanin. Through its association with CLEC2, Podoplanin-induces platelet aggregation and tumor metastasis. Podoplanin is also necessary for lymphatic vessel formation, normal lung cell proliferation and alveolus formation at birth. |
|||